Tags: rifaximinlactulosehepatic encephalopathyrespiratory insufficiencyspontaneous bacterial peritonitis
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | ||
| 2 | Andrew Paul Popular Science Now on Bluesky America's Heartland | ‘Poop pills’ tested in pancreatic cancer patients - about 2 months ago | |
| 3 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | ||
| 4 | David Nield Science Alert Freelance tech, science writer. Marple, Manchester, UK | ||
| 5 | Kristen Monaco MedPage Today | Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It? - about 1 year ago One-Week GLP-1 Agonist Hold Not Enough Before Anesthesia? - about 1 year ago Breast Cancer Drug Repurposed for Infant With Congenital Hyperinsulinism - about 1 year ago FDA OKs Product to Thwart Bloodstream Infections During Dialysis - over 1 year ago FDA Approves First Phosphate Absorption Inhibitor for CKD - over 1 year ago | |
| 6 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 7 | Tara Haelle MedPage Today Sci/health journalist.
Feminist.
Educator.
Photographer.
Author. DFW | SGLT2 Inhibitors Tied to Better NAFLD Outcomes vs Other Antidiabetic Agents - about 1 year ago Rectal Botox Injections Improved Fecal Incontinence, Urgency - over 1 year ago | |
| 8 | Ian Ingram MedPage Today Deputy Managing Editor.
MedPage Today. New York, New York | FDA OKs Maintenance Option for High-Risk Neuroblastoma - over 1 year ago | |
| 9 | Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location | Ocaliva's Takedown by FDA Panel - 7 months ago | |
| 10 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | FDA Panel Rejects SGLT1/2 Inhibitor for Type 1 Diabetes - 6 months ago New First-Line Option for Pancreatic Cancer Approved - about 1 year ago |